BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24889722)

  • 21. Increased interactions and engulfment of dendrites by microglia precede Purkinje cell degeneration in a mouse model of Niemann Pick Type-C.
    Kavetsky L; Green KK; Boyle BR; Yousufzai FAK; Padron ZM; Melli SE; Kuhnel VL; Jackson HM; Blanco RE; Howell GR; Soto I
    Sci Rep; 2019 Oct; 9(1):14722. PubMed ID: 31605022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
    Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological cholesterol metabolism fails to modify electrophysiological properties of afflicted neurones in Niemann-Pick disease type C.
    Deisz RA; Meske V; Treiber-Held S; Albert F; Ohm TG
    Neuroscience; 2005; 130(4):867-73. PubMed ID: 15652985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
    Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
    Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Niemann-Pick type C transcript in rodent cerebellum in vivo and in vitro.
    Falk T; Garver WS; Erickson RP; Wilson JM; Yool AJ
    Brain Res; 1999 Aug; 839(1):49-57. PubMed ID: 10482798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose tissue-derived stem cells rescue Purkinje neurons and alleviate inflammatory responses in Niemann-Pick disease type C mice.
    Bae JS; Carter JE; Jin HK
    Cell Tissue Res; 2010 May; 340(2):357-69. PubMed ID: 20238127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of GABAergic Input Precedes Neurodegeneration of Cerebellar Purkinje Cells of NPC1-Deficient Mice.
    Rabenstein M; Murr N; Hermann A; Rolfs A; Frech MJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice.
    Alam MS; Cooper B; Farris JD; Haldar K
    Sci Rep; 2018 Mar; 8(1):3875. PubMed ID: 29497113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
    Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
    Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystonia and cerebellar degeneration in the leaner mouse mutant.
    Raike RS; Hess EJ; Jinnah HA
    Brain Res; 2015 Jun; 1611():56-64. PubMed ID: 25791619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adult form of Niemann-Pick disease type C.
    Sévin M; Lesca G; Baumann N; Millat G; Lyon-Caen O; Vanier MT; Sedel F
    Brain; 2007 Jan; 130(Pt 1):120-33. PubMed ID: 17003072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
    Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
    Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability.
    Meske V; Erz J; Priesnitz T; Ohm TG
    Neurobiol Dis; 2014 Apr; 64():88-97. PubMed ID: 24412309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
    Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Navid F; Wassif CA; Cawley NX; Porter FD
    Mol Genet Metab; 2021 Dec; 134(4):330-336. PubMed ID: 34802899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
    Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
    Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trehalose enhances mitochondria deficits in human NPC1 mutant fibroblasts but disrupts mouse Purkinje cell dendritic growth ex vivo.
    MacLeod CM; Yousufzai FAK; Spencer LT; Kim S; Rivera-Rosario LA; Barrera ZD; Walsh L; Krummenacher C; Carone B; Soto I
    PLoS One; 2023; 18(11):e0294312. PubMed ID: 38033125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
    Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T
    Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.
    Soga M; Ishitsuka Y; Hamasaki M; Yoneda K; Furuya H; Matsuo M; Ihn H; Fusaki N; Nakamura K; Nakagata N; Endo F; Irie T; Era T
    Stem Cells; 2015 Apr; 33(4):1075-88. PubMed ID: 25522247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
    Ory DS; Ottinger EA; Farhat NY; King KA; Jiang X; Weissfeld L; Berry-Kravis E; Davidson CD; Bianconi S; Keener LA; Rao R; Soldatos A; Sidhu R; Walters KA; Xu X; Thurm A; Solomon B; Pavan WJ; Machielse BN; Kao M; Silber SA; McKew JC; Brewer CC; Vite CH; Walkley SU; Austin CP; Porter FD
    Lancet; 2017 Oct; 390(10104):1758-1768. PubMed ID: 28803710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.